Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. In an article, author is Ghatak, Tapas, once mentioned the application of 98796-51-1, Name is 5′-O-[Bis(4-Methoxyphenyl)phenylmethyl]-thymidine 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], molecular formula is C40H49N4O8P. Now introduce a scientific discovery about this category, Product Details of 98796-51-1.
Two cyclometalated compounds [(IrCl)-Cl-III{(2-biphenylene-1,8-naphthyridine-kappa C,N}(eta (5)-pentamethylcyclopentadienyl)] (1) and [(IrCl)-Cl-III{(2-(2-N-Methyl-pyrrolyl-1,8-naphthyridine-kappa C,N}(eta (5)-pentamethylcyclopentadienyl)] (2) containing naphthyridine based ligands have been synthesized in high yield. Insertion of SnCl2 to a terminal Ir-Cl bond of 1 affords the mixed Ir-SnCl3 compound [(IrSnCl3)-Sn-III{(2-biphenylene-1,8-naphthyridine-kappa C,N}(eta (5)-pentamethylcyclopentadienyl)] (3). The heterobimetallic compound 3 is shown to be an excellent catalyst for a variety of cyanosilylation reactions. A cooperative mechanism has been proposed which involves the simultaneous activation of aldehyde and cyanide precursor by Sn and unbound naphthyridine nitrogen.
Future efforts will undeniably focus on the diversification of the new catalytic transformations. In my other articles, you can also check out more blogs about 98796-51-1. Product Details of 98796-51-1.
Reference:
1,8-Naphthyridine – Wikipedia,
,1,8-Naphthyridine | C8H6N2 – PubChem